RxSight, Inc.'s (NASDAQ:RXST) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors

Simply Wall StDec 26 05:00 ET

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT NewswiresDec 20 15:57 ET

RxSight Down Over 13%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Dow JonesDec 20 15:35 ET

Stifel Downgrades RxSight(RXST.US) to Hold Rating, Cuts Target Price to $40

Moomoo NewsDec 20 13:31 ET · Ratings

Hold Rating Issued Amidst Rising Competition and Market Uncertainty for RxSight

TipRanksDec 20 12:58 ET · Ratings

RxSight Cut to Hold at Stifel on Competition Concerns

Seeking AlphaDec 20 10:43 ET